BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38839983)

  • 1. Machine learning survival prediction using tumor lipid metabolism genes for osteosarcoma.
    Li S; Zheng Z; Wang B
    Sci Rep; 2024 Jun; 14(1):12934. PubMed ID: 38839983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a 3-gene signature based on differentially expressed invasion genes related to cancer molecular subtypes to predict the prognosis of osteosarcoma patients.
    Wan Y; Qu N; Yang Y; Ma J; Li Z; Zhang Z
    Bioengineered; 2021 Dec; 12(1):5916-5931. PubMed ID: 34488541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of CD8 Tex cell-associated gene signatures in the prognosis and immunology of osteosarcoma.
    Lu Y; Cao N; Zhao M; Zhang G; Zhang Q; Wang L
    Sci Rep; 2024 Apr; 14(1):9769. PubMed ID: 38684858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel risk score model based on eight genes and a nomogram for predicting overall survival of patients with osteosarcoma.
    Wu G; Zhang M
    BMC Cancer; 2020 May; 20(1):456. PubMed ID: 32448271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integration of single-cell RNA sequencing and bulk RNA sequencing to reveal an immunogenic cell death-related 5-gene panel as a prognostic model for osteosarcoma.
    Yang J; Zhang J; Na S; Wang Z; Li H; Su Y; Ji L; Tang X; Yang J; Xu L
    Front Immunol; 2022; 13():994034. PubMed ID: 36225939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A risk signature-based on metastasis-associated genes to predict survival of patients with osteosarcoma.
    Shi Y; He R; Zhuang Z; Ren J; Wang Z; Liu Y; Wu J; Jiang S; Wang K
    J Cell Biochem; 2020 Jul; 121(7):3479-3490. PubMed ID: 31898371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterizing the critical role of metabolism in osteosarcoma based on establishing novel molecular subtypes.
    Zhang WB; Han FM; Liu LM; Jin HB; Yuan XY; Shang HS
    Eur Rev Med Pharmacol Sci; 2022 Apr; 26(8):2926-2943. PubMed ID: 35503637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of immune-related genes as prognostic biomarkers for the assessment of osteosarcoma clinical outcomes.
    Guo J; Li X; Shen S; Wu X
    Sci Rep; 2021 Dec; 11(1):24123. PubMed ID: 34916564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Four-Pseudogene Classifier Identified by Machine Learning Serves as a Novel Prognostic Marker for Survival of Osteosarcoma.
    Liu F; Xing L; Zhang X; Zhang X
    Genes (Basel); 2019 May; 10(6):. PubMed ID: 31146489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene Expression Classifier Reveals Prognostic Osteosarcoma Microenvironment Molecular Subtypes.
    Song YJ; Xu Y; Deng C; Zhu X; Fu J; Chen H; Lu J; Xu H; Song G; Tang Q; Wang J
    Front Immunol; 2021; 12():623762. PubMed ID: 33959121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The tumor immune microenvironment and immune-related signature predict the chemotherapy response in patients with osteosarcoma.
    He L; Yang H; Huang J
    BMC Cancer; 2021 May; 21(1):581. PubMed ID: 34016089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of an Autophagy-Related Clinical Prognosis Model for Predicting the Overall Survival of Osteosarcoma.
    Li J; Tang X; Du Y; Dong J; Zhao Z; Hu H; Song T; Guo J; Wang Y; Xu T; Shao C; Sheng Y; Xi Y
    Biomed Res Int; 2021; 2021():5428425. PubMed ID: 34604383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammasome-related gene signatures as prognostic biomarkers in osteosarcoma.
    Zhang N; Han Y; Cao H; Wang Q
    J Cell Mol Med; 2024 May; 28(9):e18286. PubMed ID: 38742843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signature based on metabolic-related gene pairs can predict overall survival of osteosarcoma patients.
    Li LQ; Zhang LH; Yuan YB; Lu XC; Zhang Y; Liu YK; Wen J; Khader MA; Liu T; Li JZ; Zhang Y
    Cancer Med; 2021 Jul; 10(13):4493-4509. PubMed ID: 34047495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioinformatics analysis and validation of mesenchymal stem cells related gene MT1G in osteosarcoma.
    Zheng S; Cheng X; Ke S; Zhang L; Wu H; He D; Cheng X
    Aging (Albany NY); 2024 May; 16(9):8155-8170. PubMed ID: 38747739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 12 Survival-related differentially expressed genes based on the TARGET-osteosarcoma database.
    Rothzerg E; Xu J; Wood D; Kõks S
    Exp Biol Med (Maywood); 2021 Oct; 246(19):2072-2081. PubMed ID: 33926256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of critical genes associated with human osteosarcoma metastasis based on integrated gene expression profiling.
    Fan H; Lu S; Wang S; Zhang S
    Mol Med Rep; 2019 Aug; 20(2):915-930. PubMed ID: 31173206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigating age‑induced differentially expressed genes and potential molecular mechanisms in osteosarcoma based on integrated bioinformatics analysis.
    Wang JS; Duan MY; Zhong YS; Li XD; Du SX; Xie P; Zheng GZ; Han JM
    Mol Med Rep; 2019 Apr; 19(4):2729-2739. PubMed ID: 30720085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a novel six DNA damage response-related prognostic signature in osteosarcoma.
    Li T; Tang Z; Li S; Lu M
    Cell Mol Biol (Noisy-le-grand); 2024 Mar; 70(3):110-115. PubMed ID: 38650147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Signature of Osteosarcoma Based on 14 Autophagy-Related Genes.
    Qi W; Yan Q; Lv M; Song D; Wang X; Tian K
    Pathol Oncol Res; 2021; 27():1609782. PubMed ID: 34335109
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.